obtaining

Implanet strengthens intellectual property protection of JAZZ through 2032 by obtaining a key United States patent

Bordeaux, Boston, August 30, 2016 – IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible; OTCQX: IMPZY), a medical technology company specializing in…